Skip to main content
  • AACR Publications
    • Cancer Discovery
    • Cancer Epidemiology, Biomarkers & Prevention
    • Cancer Immunology Research
    • Cancer Prevention Research
    • Cancer Research
    • Clinical Cancer Research
    • Molecular Cancer Research
    • Molecular Cancer Therapeutics

  • Register
  • Log in
Advertisement

Main menu

  • Home
  • About
    • The Journal
    • AACR Journals
    • Subscriptions
    • Permissions and Reprints
    • Reviewing
  • Articles
    • OnlineFirst
    • Current Issue
    • Past Issues
    • Focus on Computer Resources
    • 75th Anniversary
    • Meeting Abstracts
  • For Authors
    • Information for Authors
    • Author Services
    • Best of: Author Profiles
    • Submit
  • Alerts
    • Table of Contents
    • OnlineFirst
    • Editors' Picks
    • Citations
    • Author/Keyword
  • News
    • Cancer Discovery News
  • AACR Publications
    • Cancer Discovery
    • Cancer Epidemiology, Biomarkers & Prevention
    • Cancer Immunology Research
    • Cancer Prevention Research
    • Cancer Research
    • Clinical Cancer Research
    • Molecular Cancer Research
    • Molecular Cancer Therapeutics

User menu

  • Register
  • Log in

Search

  • Advanced search
Cancer Research
Cancer Research

Advanced Search

  • Home
  • About
    • The Journal
    • AACR Journals
    • Subscriptions
    • Permissions and Reprints
    • Reviewing
  • Articles
    • OnlineFirst
    • Current Issue
    • Past Issues
    • Focus on Computer Resources
    • 75th Anniversary
    • Meeting Abstracts
  • For Authors
    • Information for Authors
    • Author Services
    • Best of: Author Profiles
    • Submit
  • Alerts
    • Table of Contents
    • OnlineFirst
    • Editors' Picks
    • Citations
    • Author/Keyword
  • News
    • Cancer Discovery News
Retraction

Retraction: High-Avidity T Cells Are Preferentially Tolerized in the Tumor Microenvironment

DOI: 10.1158/0008-5472.CAN-16-0506
  • Article
  • Info & Metrics
  • PDF
Loading

The editors and authors retract the article titled “High-Avidity T Cells Are Preferentially Tolerized in the Tumor Microenvironment,” which was published in the January 15, 2013 issue of Cancer Research (1), based on the findings of data falsification regarding Fig. 5A. Following review by an NIH investigation committee, NIH found the author Stephanie Watkins was the sole individual responsible for the instances of research misconduct. None of the other authors were aware of the misconduct.

Six of the seven authors have agreed to this retraction and they are as follows:

Ziqiang Zhu

Tumor Immunity and Tolerance Section, Laboratory of Molecular Immunoregulation, Cancer and Inflammation Program, Frederick National Laboratory for Cancer Research, Frederick, Maryland

Vinod Singh

Tumor Immunity and Tolerance Section, Laboratory of Molecular Immunoregulation, Cancer and Inflammation Program, Frederick National Laboratory for Cancer Research, Frederick, Maryland

Vincenzo Bronte

Department of Pathology, University of Verona, Verona, Italy

Jennifer L. Shoe

Laboratory Animal Sciences Program, SAIC-Frederick, NCI, Frederick, Maryland

Lionel Feigenbaum

Laboratory Animal Sciences Program, SAIC-Frederick, NCI, Frederick, Maryland

Arthur A. Hurwitz

Tumor Immunity and Tolerance Section, Laboratory of Molecular Immunoregulation, Cancer and Inflammation Program, Frederick National Laboratory for Cancer Research, Frederick, Maryland

  • ©2016 American Association for Cancer Research.

Reference

  1. 1.↵
    1. Zhu Z,
    2. Singh V,
    3. Watkins SK,
    4. Bronte V,
    5. Shoe JL,
    6. Feigenbaum L,
    7. et al.
    High-avidity T cells are preferentially tolerized in the tumor microenvironment. Cancer Res 2013;73:595–604.
    OpenUrlAbstract/FREE Full Text
Next
Back to top

Published OnlineFirst March 24, 2016
doi: 10.1158/0008-5472.CAN-16-0506

View this article with LENS

Open full page PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for sharing this Cancer Research article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
Retraction: High-Avidity T Cells Are Preferentially Tolerized in the Tumor Microenvironment
(Your Name) has forwarded a page to you from Cancer Research
(Your Name) thought you would be interested in this article in Cancer Research.
Citation Tools
Retraction: High-Avidity T Cells Are Preferentially Tolerized in the Tumor Microenvironment
Cancer Res March 24 2016 DOI: 10.1158/0008-5472.CAN-16-0506

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Retraction: High-Avidity T Cells Are Preferentially Tolerized in the Tumor Microenvironment
Cancer Res March 24 2016 DOI: 10.1158/0008-5472.CAN-16-0506
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Reference
  • Info & Metrics
  • PDF
Advertisement

Related Articles

Cited By...

More in this TOC Section

  • Retraction: CYP1B1 Gene Polymorphisms Have Higher Risk for Endometrial Cancer, and Positive Correlations with Estrogen Receptor α and Estrogen Receptor β Expressions
  • Retraction: Abstract 408: ACP-196, An Orally Bioavailable Covalent Selective Inhibitor of Btk, Modulates the Innate Tumor Microenvironment, Exhibits Antitumor Efficacy and Enhances Gemcitabine Activity in Pancreatic Cancer
  • Retraction: Molecular Mechanism of MART-1+/A*0201+ Human Melanoma Resistance to Specific CTL-Killing Despite Functional Tumor–CTL Interaction
Show more Retraction
  • Home
  • Alerts
  • Feedback
Facebook  Twitter  LinkedIn  YouTube  RSS

Articles

  • Online First
  • Current Issue
  • Past Issues
  • Meeting Abstracts

Info for

  • Authors
  • Subscribers
  • Advertisers
  • Librarians
  • Reviewers

About Cancer Research

  • About the Journal
  • Editorial Board
  • Permissions
  • Submit a Manuscript
AACR logo

Copyright © 2018 by the American Association for Cancer Research.

Cancer Research Online ISSN: 1538-7445
Cancer Research Print ISSN: 0008-5472
Journal of Cancer Research ISSN: 0099-7013
American Journal of Cancer ISSN: 0099-7374

Advertisement